论文部分内容阅读
72例糖尿病胃轻瘫患者随机分为2组,36例治疗组口服莫沙比利加六味能消胶囊,36例对照组口服莫沙比利口服治疗,疗程均为30天,观察治疗前后胃轻瘫症状改变及上消化道钡餐透视情况。结果:治疗组显效率为47.2%,总有效率为88.9%,对照组显效率为27.8%,总有效率为66.7%。结论:莫沙比利和六味能消胶囊联合优于单用莫沙比利治疗糖尿病胃轻瘫,且副作用小,服用方便,值得临床推广。
72 cases of diabetic gastroparesis patients were randomly divided into two groups, 36 cases of treatment group oral mosapride plus Liu Wei Neng capsule, 36 cases of control group oral mosapride oral treatment, the course of treatment were 30 days, before and after treatment of gastric light Paralysis symptoms and upper gastrointestinal barium meal perspective. Results: The effective rate of the treatment group was 47.2%, the total effective rate was 88.9%, the effective rate of the control group was 27.8%, the total effective rate was 66.7%. Conclusion: Combination of Mosapride and Liuwei Nengxiao Capsule is superior to Mosapride alone in the treatment of diabetic gastroparesis, and its side effects are small and convenient to take. It is worthy of clinical promotion.